Gabrielle Nicole Frumusa, PA | |
1555 Long Pond Rd, Rochester, NY 14626-4122 | |
(585) 723-7000 | |
Not Available |
Full Name | Gabrielle Nicole Frumusa |
---|---|
Gender | Female |
Speciality | Physician Assistant - Medical |
Location | 1555 Long Pond Rd, Rochester, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124646773 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XS0106X | Orthopaedic Surgery - Hand Surgery | 25407 (New York) | Secondary |
363AM0700X | Physician Assistant - Medical | 025407 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gabrielle Nicole Frumusa, PA 100 Kings Hwy S, Rochester, NY 14617-5504 Ph: (585) 723-7870 | Gabrielle Nicole Frumusa, PA 1555 Long Pond Rd, Rochester, NY 14626-4122 Ph: (585) 723-7000 |
News Archive
Looking beyond the picky eating of childhood, researchers looked at this behavior in college students. Self-identified picky eaters ate significantly less fiber and vegetables and reported greater levels of social phobia than non-picky eaters, according to a new study in the Journal of Nutrition Education and Behavior, published by Elsevier.
During the COVID-19 pandemic, social distancing and stay-at-home orders have been enacted throughout the world to stop disease transmission and keep people safe.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.
A new study used a combination of a computer-aided drug design approach and cell-based in vitro assays to identify five potential SARS-CoV-2 inhibitors.
› Verified 6 days ago